Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals
- 20 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (4) , 545-555
Abstract
Objective: To assess the association of hepatitis B virus (HBV) vaccination with risk of HBV infection among HIV-infected patients and HBV infection risk factors among vaccinees. Design: Observational cohort study. Methods: Participants enrolled from 1986 through 2004, unvaccinated and serologically negative for HBV infection at the time of HIV diagnosis, were followed longitudinally through 2007 for the occurrence of HBV infection. Risk factors for HBV infection were evaluated using time to event methods, including Kaplan–Meier survival curves and Cox proportional hazards models. Results: During 11 632 person-years of follow-up, the rate of HBV infection was 2.01 (95% CI 1.75–2.27)/100 person-years. Receipt of at least one dose of vaccine was not associated with reduced risk of HBV (unadjusted hazard ratio 0.86, 95% CI 0.7–1.1; adjusted hazard ratio 1.08, 95% CI 0.8–1.4). Receipt of three or more doses of vaccine was also not associated with reduced risk (hazard ratio 0.96; 95% CI 0.56–1.64). Among 409 vaccinees with HBsAb less than 10 IU/l, 46 (11.2%) developed HBV infection compared with 11 of 217 (5.1%) vaccinees with HBsAb ≥10 IU/l (hazard ratio 0.51; 95% CI 0.3–1.0). In participants with initial HBsAb less than 10 IU/l, 16 of 46 (35%) infections were chronic, compared with none of 11 in those with initial HBsAb at least 10 IU/l (P = 0.02). Conclusion: Overall, HBV vaccination was not associated with reduced risk of HBV infection in our cohort of HIV-infected individuals. However, the small subset of vaccinees with a positive vaccine response may have had reduced HBV infection risk, including chronic disease. Improvements in vaccine delivery and immunogenicity are needed to increase HBV vaccine effectiveness in HIV-infected patients.Keywords
This publication has 53 references indexed in Scilit:
- A STEP into Darkness or Light?Science, 2008
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Hepatitis B in the Human Immunodeficiency Virus-Infected Patient: Epidemiology, Natural History, and TreatmentSeminars in Liver Disease, 2003
- Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine responseAddiction, 2002
- Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohortJournal of Adolescent Health, 2001
- Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individualsAIDS, 1994
- Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.Journal of Experimental Medicine, 1992
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983
- Hepatitis B VaccineNew England Journal of Medicine, 1980